HomeGUD • TSE
add
Knight Therapeutics Inc
Previous close
$6.14
Day range
$6.10 - $6.17
Year range
$4.35 - $6.22
Market cap
617.84M CAD
Avg Volume
58.87K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
The Motley Fool
9 hours ago
Want to Beat the S&P 500? History Says Avoid This Top Warren Buffett Stock
0.68%
0.12%
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 86.60M | 4.85% |
Operating expense | 39.04M | 11.13% |
Net income | -4.55M | -15.47% |
Net profit margin | -5.25 | -10.06% |
Earnings per share | -0.04 | 0.00% |
EBITDA | 15.24M | -18.57% |
Effective tax rate | 36.37% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 192.25M | 8.15% |
Total assets | 968.20M | -7.33% |
Total liabilities | 206.32M | -8.67% |
Total equity | 761.89M | — |
Shares outstanding | 101.17M | — |
Price to book | 0.82 | — |
Return on assets | 0.69% | — |
Return on capital | 0.81% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -4.55M | -15.47% |
Cash from operations | 30.88M | 732.15% |
Cash from investing | -24.37M | -179.62% |
Cash from financing | -2.90M | 74.29% |
Net change in cash | 4.07M | 126.35% |
Free cash flow | 634.88K | 104.06% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
725
